allocating 340b vials to friends to boost IC for Krystexxa?

Quote



anonymous said:
Not sure the "Amgen" culture will take over that fast. It’s not like they are going to replace all of our upper and mid management team. They didn't with Chemocentryx. We will be better off without you for sure.
Click to expand...

How credit for IC works has nothing to do with culture. It has to do with liability. Just like every other decent sized pharma company, no part of IC determination will be left to sales management’s discretion at Amgen. Strict, black and white rules will be put in place to avoid any potential for a lawsuit. Chemocentyx’s leadership may not have changed, but their IC structure and rules did the very first full quarter after the deal was finalized. Feel free to ask any of the reps to confirm.
 




anonymous said:
How credit for IC works has nothing to do with culture. It has to do with liability. Just like every other decent sized pharma company, no part of IC determination will be left to sales management’s discretion at Amgen. Strict, black and white rules will be put in place to avoid any potential for a lawsuit. Chemocentyx’s leadership may not have changed, but their IC structure and rules did the very first full quarter after the deal was finalized. Feel free to ask any of the reps to confirm.
Click to expand...

Everything changed for the better for them. More money and easier compliance. Ask them.
 






anonymous said:
And neither does Horizon.
Click to expand...

By all means, go ask your manager for the a copy of the rules for credit vials/starts outside of territory and for doctors who practice in more than one territory. Then ask who makes that decision. Oh, and read the fine print on your IC plan document. Theirs IS a section about shared credit that states “Horizon retains right to make all determinations with respect to shared credit prescribers at its discretion”.
Suck on that.
 


anonymous said:
By all means, go ask your manager for the a copy of the rules for credit vials/starts outside of territory and for doctors who practice in more than one territory. Then ask who makes that decision. Oh, and read the fine print on your IC plan document. Theirs IS a section about shared credit that states “Horizon retains right to make all determinations with respect to shared credit prescribers at its discretion”.
Suck on that.
Click to expand...


no proof, no prooof, no prooooofff.

we still giving it to who we want to have a good scores going in to Amgen and they ain't nothin you can do because

no proof
 












anonymous said:
only when we are trying to help someone or hurt someone

read your damn documents or email you dm and watch the scramble.
Click to expand...

You are wrong. Not everything is rigged against you. What you are suggesting is just flat out false.

People are so quick to pat themselves on the back when they beat goal but it is always someone else’s fault when they miss goal. Spend more time selling and less complaining on this forum and maybe you’ll get somewhere.
 


I don’t know about the 340b vials, but the part about management making decisions on who gets credit for vials outside of territory & for docs that go to multiple territories IS decided on a case by case basis by management. Go ask the KC & IA RSAMs.
 




anonymous said:
If you understand how 340b works...you would understand why some 340b vials should count towards your goal.
Click to expand...

Uh, if it was an actual 340b vial, then no. If it was a vial bought by a 340b facility but not at the 340b price, then you should get credit (not a 340b vial then). Academic centers especially can have a mix. The hospital purchases for their own infusion centers, but then the physicians group (still with the university name in it) can have their own infusion center in office on campus. Plus, there’s some 340b hospitals that are not purchasing all vials at 340b price because certain state medicaids are cracking down on the discount double dipping - actually requiring documentation of the price of the vial. Then there’s critical access hospitals which are 340b, but don’t get 340b pricing for orphan status drugs. I’ve been appalled at how many people here don’t understand. Either way, it should be obvious if was purchased at 340b price or notust by the net revenue listed in BI.
THAT BEING SAID, I don’t personally know of an instance where someone got credit for true 340b vials, BUT the posts about sales leadership deciding who gets credit for vials outside of territory & for shared doctors on a case by case basis is 100% true - there is no set rule. To the idiot that keeps posting about proof, that is easily obtained for that. It’s not something that leadership is ashamed of or trying to hide. Just ask them!
 


FAX are that we are using this special period to allocate to who we want and keep from who we don't as we head into Amgen World.


You shouldn't be a trouble maker and you might get some.
 


anonymous said:
Uh, if it was an actual 340b vial, then no. If it was a vial bought by a 340b facility but not at the 340b price, then you should get credit (not a 340b vial then). Academic centers especially can have a mix. The hospital purchases for their own infusion centers, but then the physicians group (still with the university name in it) can have their own infusion center in office on campus. Plus, there’s some 340b hospitals that are not purchasing all vials at 340b price because certain state medicaids are cracking down on the discount double dipping - actually requiring documentation of the price of the vial. Then there’s critical access hospitals which are 340b, but don’t get 340b pricing for orphan status drugs. I’ve been appalled at how many people here don’t understand. Either way, it should be obvious if was purchased at 340b price or notust by the net revenue listed in BI.
THAT BEING SAID, I don’t personally know of an instance where someone got credit for true 340b vials, BUT the posts about sales leadership deciding who gets credit for vials outside of territory & for shared doctors on a case by case basis is 100% true - there is no set rule. To the idiot that keeps posting about proof, that is easily obtained for that. It’s not something that leadership is ashamed of or trying to hide. Just ask them!
Click to expand...

Tell us you really think you know how 340b works...but really don't.
 


All I will say is suddenly, I am getting credit for these vials from outside my territory. Doesn't feel right. Especially when I see them withholding from the people they don't like. I guess I'll take it so my numbers look great for Amgen, but I see what's going on.
 



Write your reply...
Top Bottom
Back
Quote